Drug Information
| General Information | ||||||
|---|---|---|---|---|---|---|
| Drug ID |
DR00552
|
|||||
| Drug Name |
Imipramine
|
|||||
| Synonyms |
1-(3-Dimethylaminopropyl)-4,5-dihydro-2,3,6,7-dibenzazepine; 10,11-Dihydro-5-(3-(dimethylamino)propyl)-5H-dibenz[b,f]azepine; 10,11-Dihydro-N,N-dimethyl-5H-dibenz[b,f]azepine-5-propanamine; 2,2'-(3-Dimethylaminopropylimino)bibenzyl; 2,2'-(3-Dimethylaminopropylimino)dibenzyl; 3-(10,11-dihydro-5H-dibenzo[b,f]azepin-5-yl)-N,N-dimethylpropan-1-amine; 3-(5,6-dihydrobenzo[b][1]benzazepin-11-yl)-N,N-dimethylpropan-1-amine; 5,6-Dihydro-N-(3-(dimethylamino)propyl)-11H-dibenz(b,e)azepine; 5,6-Dihydro-N-[3-(dimethylamino)propyl]-11H-dibenz[b,e]azepine; 5-(3-(Dimethylamino)propyl)-10,11-dihydro-5H-dibenz(b,f)azepine; 5-(3-Dimethylaminopropyl)-10,11-dihydro-5H-dibenzo(b,f)azepine; 5H-Dibenz(b,f)azepine,5-[3-(dimethylamino)propyl]-10,11-dihydro-mixed with ethyl alcohol; 5H-Dibenz(b,f)azepine-5-propanamine, 10,11-dihydro-N,N-dimethyl-(9CI); Antideprin; Antideprin (TN); Berkomine; Censtim; Censtin; Declomipramine; Deprimin (TN); Deprinol (TN); Depsonil (TN); Dimipressin; Dpid; Dyna-zina; Dynaprin; Dynaprin (TN); Eupramin; Eupramin (TN); G-22355; Imavate; Imidobenzyle; Imipramil (TN); Imipramin; Imipramina; Imipramina [INN-Spanish]; Imipramina [Italian]; Imipramine (INN); Imipramine [INN:BAN]; Imipraminum; Imipraminum [INN-Latin]; Imiprin; Imizin; Imizinum; Impramine; Intalpram; Iramil; Irmin; Irmin (TN); Janimine; Janimine (TN); Janimine (hydrochloride); Melipramin; Melipramin (TN); Melipramine; N-(3-Dimethylaminopropyl)-o-iminodibenzyl; N-(gamma-Dimethylaminopropyl)iminodibenzyl; N-(gamma.-Dimethylaminopropyl)iminodibenzyl; Nelipramin; Norchlorimipramine; Norfranil; Pramine; Prazepine; Promiben;Psychoforin; SK-Pramine; Surplix; Surplix (TN); Timolet; Tofranil; Tofranil (free base); Tofranil (hydrochloride); Tofranil(TN); Tofranil, base; Tofraniln A
|
|||||
| Drug Type |
Small molecular drug
|
|||||
| Indication | Major depressive disorder [ICD11: 6A70.3] | Approved | [1] | |||
| Therapeutic Class |
Antidepressants
|
|||||
| Structure |
|
 |
||||
| 3D MOL | 2D MOL | |||||
| Formula |
C19H24N2
|
|||||
| Canonical SMILES |
CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31
|
|||||
| InChI |
InChI=1S/C19H24N2/c1-20(2)14-7-15-21-18-10-5-3-8-16(18)12-13-17-9-4-6-11-19(17)21/h3-6,8-11H,7,12-15H2,1-2H3
|
|||||
| InChIKey |
BCGWQEUPMDMJNV-UHFFFAOYSA-N
|
|||||
| CAS Number |
CAS 50-49-7
|
|||||
| Pharmaceutical Properties | Molecular Weight | 280.4 | Topological Polar Surface Area | 6.5 | ||
| Heavy Atom Count | 21 | Rotatable Bond Count | 4 | |||
| Hydrogen Bond Donor Count | 0 | Hydrogen Bond Acceptor Count | 2 | |||
| XLogP |
4.8
|
|||||
| PubChem CID | ||||||
| PubChem SID |
10524418
, 11111330
, 11111331
, 11335734
, 11360973
, 11363809
, 11366371
, 11368933
, 11371492
, 11373530
, 11377095
, 11461945
, 11466100
, 11467220
, 11484795
, 11485940
, 11488806
, 11490282
, 11491831
, 11494729
, 15222228
, 26751600
, 29214791
, 29222819
, 3249403
, 442469
, 46507351
, 47365159
, 47588968
, 47736449
, 47736450
, 47736451
, 47810727
, 47885381
, 48110430
, 48110431
, 49698865
, 49761601
, 49961519
, 50100256
, 50104254
, 53788900
, 57288535
, 57321945
, 615226
, 7548657
, 7849629
, 7979599
, 8152336
, 9261
|
|||||
| ChEBI ID |
ChEBI:47499
|
|||||
| TTD Drug ID | ||||||
| DT(s) Transporting This Drug | P-GP | Transporter Info | P-glycoprotein 1 | Substrate | [2] | |
| References | ||||||
| 1 | Imipramine was approved by FDA. The official website of the U.S. Food and Drug Administration. (2019) | |||||
| 2 | Caco-2 permeability, P-glycoprotein transport ratios and brain penetration of heterocyclic drugs. Int J Pharm. 2003 Sep 16;263(1-2):113-22. | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.